Rigel Pharmaceuticals Inc... (RIGL)

AI Score

Unlock

16.84

0.35 (2.12%)

At close: Apr 17, 2025, 3:59 PM

17.25

2.49%

After-hours: Apr 17, 2025, 07:56 PM EDT

Rigel Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	56.75M	32.79M	24.46M	18.89M	30.37M	22.52M	76.32M	38.29M	17.63M
Short-Term Investments	20.57M	24.15M	33.75M	106.08M	26.95M	75.56M	52.22M	77.46M	57.13M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.44M	3.06M	640K	974K	824K	696K	735K	803K	764K
Receivables	41.62M	30.55M	40.32M	15.47M	15.97M	10.11M	4.08M	n/a	n/a
Inventory	6M	5.52M	9.12M	6.62M	1.64M	1.35M	894K	n/a	n/a
Other Current Assets	10.16M	6.26M	8.26M	7.41M	n/a	9.46M	3.48M	1.68M	1.45M
Total Current Assets	135.1M	99.27M	115.9M	154.47M	88.98M	119M	136.99M	117.43M	76.21M
Property-Plant & Equipment	338K	1.03M	2.79M	11.89M	20.57M	27.87M	1.39M	875K	1.16M
Goodwill & Intangibles	27.1M	13.88M	14.95M	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	28.87M	17.96M	18.38M	12.86M	21.39M	28.56M	2.12M	1.68M	1.92M
Total Assets	163.98M	117.22M	134.28M	167.33M	110.38M	147.57M	139.11M	119.11M	78.13M
Account Payables	3.34M	7.14M	22.51M	3.79M	3.71M	4.15M	6.39M	2.64M	5.56M
Deferred Revenue	1.35M	1.35M	13.51M	2.6M	3.02M	25.29M	1.03M	-284K	-3.22M
Short-Term Debt	7.56M	7.92M	1.13M	9.89M	8.62M	7.27M	n/a	n/a	n/a
Other Current Liabilities	51.05M	27.31M	24.88M	26.69M	7.28M	5.41M	10.36M	284K	6.03M
Total Current Liabilities	63.3M	53.27M	65.21M	63.55M	40.84M	58.21M	27.73M	18.34M	22.59M
Long-Term Debt	52.41M	52.37M	39.45M	19.91M	19.82M	9.81M	n/a	n/a	n/a
Other Long-Term Liabilities	44.98M	39.94M	42.26M	52.73M	5.04M	5.1M	90K	128K	519K
Total Long-Term Liabilities	97.39M	92.6M	82.68M	73.4M	35.51M	35.54M	1.5M	128K	519K
Total Liabilities	160.69M	145.87M	147.9M	136.95M	76.35M	93.75M	29.23M	18.46M	23.11M
Total Debt	59.97M	60.58M	41.55M	30.57M	39.09M	36.31M	n/a	284K	3.46M
Common Stock	18K	175K	174K	172K	169K	168K	167K	147K	100K
Retained Earnings	-1.39B	-1.41B	-1.38B	-1.32B	-1.31B	-1.28B	-1.21B	-1.14B	-1.06B
Comprehensive Income	10K	8K	-153K	-102K	-4K	23K	-24K	-82K	-18K
Shareholders Equity	3.29M	-28.64M	-13.62M	30.37M	34.03M	53.81M	109.88M	100.65M	55.03M
Total Investments	20.57M	24.15M	33.75M	106.08M	26.95M	75.56M	52.22M	77.46M	57.13M